Fund profile by ISIN IE000AGFZM58
HSBC MSCI Europe Islamic Screened UCITS ETF EUR Acc
Research HSBC MSCI Europe Islamic Screened UCITS ETF EUR Acc by ISIN IE000AGFZM58, domicile Ireland, accumulating, and 1-year price performance +23.6%.
ISINIE000AGFZM58
TER—
DomicileIreland
Distribution policyAccumulating
Index—
Fund size143M
Holdings—
1-year price performance+23.6%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| HIPS.L | LSE | GBP | Ireland | €226K | 7,024 |
| HIEU.L | LSE | USD | Ireland | €210K | 6,640 |
| HIEU.SW | SW | USD | Ireland | €76K | 2,396 |
| HIPS.PA | XPAR | EUR | Ireland | €65K | 2,038 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund has no German listing, so a German broker may not offer it, or may route the order to a foreign venue. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 51.41% of the fund. As of 2026-08-24.
| Holding | Symbol | Weight |
|---|---|---|
| ASML Holding NV | ASML.AS | 12.50% |
| Novartis AG Registered Shares | NOVN.SW | 8.28% |
| SAP SE | SAP.DE | 5.48% |
| TotalEnergies SE | TTE.PA | 5.00% |
| ABB Ltd | ABBN.SW | 4.46% |
| Schneider Electric SE | SU.PA | 3.97% |
| AstraZeneca PLC | AZN.L | 3.72% |
| L'Oreal SA | OR.PA | 3.09% |
| Sanofi SA | SAN.PA | 2.70% |
| Novo Nordisk AS Class B | NOVO-B.CO | 2.20% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.